Head of Research, Academic Affairs, Juno Therapeutics, Inc.
Mark's main goal for these past 20+ years has been to either develop novel cell-based therapies, or enable the transition of bench-based ideas, and early phase clinical studies into commercializable, approved therapies. He holds a special interest in gene-modified T cells and hematopoietic stem cells.....and new technologies for cell processing/manufacturing, as well as technologies that can correlate cell characteristic from collection through formulation and clinical outcome.
View More Exponential Medicine Faculty
Exponential Medicine brings together top experts to inform medical leaders how technology is impacting business. View the full list of 2017 faculty: